Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schnittger

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Cytogenetics and Cell Genetics|July 28, 2001
Assignment of the human histone deacetylase 4 gene (HDAC4) to chromosome 2q37.2 by in situ hybridizationU Mahlknecht, S Schnittger, D Hoelzer
Human Genetics|March 1, 1989
A new polymorphic DNA probe pS43 derived from a flow sorted library is assigned to human chromosome 20q13S Schnittger, F Beermann, I Hansmann
Deutsche Medizinische Wochenschrift (1946)|April 15, 2005
[Mutations of the gene coding for the receptor tyrosine kinase FLT3 in acute myeloid leukemia. Significance as the disease-specific molecular marker for diagnosis, prognosis and innovative therapy approaches]K Spiekermann, W Hiddemann, S Schnittger
Cytogenetics and Cell Genetics|January 1, 1991
Chromosomal localization of the human proliferating cell nuclear antigen (PCNA) gene to or close to 20p12 by in situ hybridizationV V Rao, S Schnittger, I Hansmann
Genomics|May 1, 1991
G protein Gs alpha (GNAS 1), the probable candidate gene for Albright hereditary osteodystrophy, is assigned to human chromosome 20q12-q13.2V V Rao, S Schnittger, I Hansmann
Blood|August 26, 1998
Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donorsS Schnittger, B Wörmann, W Hiddemann, et al.
Gene|July 1, 1997
Leukemia breakpoint region in 3q21 is gene richA Rynditch, Y Pekarsky, S Schnittger, et al.
Annals of Hematology|May 6, 2004
Modern diagnostics in chronic myeloproliferative diseases (CMPDs)T Haferlach, W Kern, S Schnittger, et al.
Leukemia|March 23, 2007
The quality of molecular response to chemotherapy is predictive for the outcome of AML1-ETO-positive AML and is independent of pretreatment risk factorsM Weisser, C Haferlach, W Hiddemann, et al.
Annals of Hematology|November 15, 2003
Myelodysplastic syndrome (RARS) with +i(12p) abnormality in a patient 10 months after diagnosis and successful treatment of a mediastinal germ cell tumor (MGCT)J Christodoulou, C Schoch, S Schnittger, et al.
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Cytogenetics and Cell Genetics|July 28, 2001
Assignment of the human histone deacetylase 4 gene (HDAC4) to chromosome 2q37.2 by in situ hybridizationU Mahlknecht, S Schnittger, D Hoelzer
Human Genetics|March 1, 1989
A new polymorphic DNA probe pS43 derived from a flow sorted library is assigned to human chromosome 20q13S Schnittger, F Beermann, I Hansmann
Deutsche Medizinische Wochenschrift (1946)|April 15, 2005
[Mutations of the gene coding for the receptor tyrosine kinase FLT3 in acute myeloid leukemia. Significance as the disease-specific molecular marker for diagnosis, prognosis and innovative therapy approaches]K Spiekermann, W Hiddemann, S Schnittger
Cytogenetics and Cell Genetics|January 1, 1991
Chromosomal localization of the human proliferating cell nuclear antigen (PCNA) gene to or close to 20p12 by in situ hybridizationV V Rao, S Schnittger, I Hansmann
Genomics|May 1, 1991
G protein Gs alpha (GNAS 1), the probable candidate gene for Albright hereditary osteodystrophy, is assigned to human chromosome 20q12-q13.2V V Rao, S Schnittger, I Hansmann
Blood|August 26, 1998
Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donorsS Schnittger, B Wörmann, W Hiddemann, et al.
Gene|July 1, 1997
Leukemia breakpoint region in 3q21 is gene richA Rynditch, Y Pekarsky, S Schnittger, et al.
Annals of Hematology|May 6, 2004
Modern diagnostics in chronic myeloproliferative diseases (CMPDs)T Haferlach, W Kern, S Schnittger, et al.
Leukemia|March 23, 2007
The quality of molecular response to chemotherapy is predictive for the outcome of AML1-ETO-positive AML and is independent of pretreatment risk factorsM Weisser, C Haferlach, W Hiddemann, et al.
Annals of Hematology|November 15, 2003
Myelodysplastic syndrome (RARS) with +i(12p) abnormality in a patient 10 months after diagnosis and successful treatment of a mediastinal germ cell tumor (MGCT)J Christodoulou, C Schoch, S Schnittger, et al.
Pageof 14